HMOs Explained: Why They Are Good For The Gut

Mieke Van Den Driessche will take a closer look at an underlying genetic polymorphism which may help to explain why some people don’t respond to targeted interventions, and will introduce new ingredient 2’-Fucosyllactose.

 

NB: This webinar is only available for Health Professionals.

 

Want to read more?